摘要
目的探讨胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床效果。方法回顾性分析心内科2008年1月～2011年6月收治的106例快速心律失常患者的临床资料,将所有患者随机分为对照组和治疗组,每组各53例。对照组静脉注射胺碘酮治疗,治疗组在此基础上静注美托洛尔,比较两组的治疗效果以及药物不良反应发生情况。结果治疗组起效时间显著优于对照组,治疗组有效率为90.6%显著高于对照组的69.8%,差异具有统计学意义(P<0.05)。而两组不良反应发生情况比较差异无统计学意义。结论胺碘酮联合美托洛尔静脉注射治疗快速心律失常效果好,起效时间快,不增加并发症发生率,值得在临床上推广应用。
Objective To analyze the effects of amiodarone metoprolol intravenous treatment of tachyarrhythmias. Methods A analysis of 106 cases of tachyarrhythmias in patients admitted by our hospital, were divided into two groups, of which 53 cases of amiodarone therapy for the control group, the remaining 53 cases for the treatment group based on intravenous metoprolol, compared between two groups of treatment and adverse drug reactions. Results The onset time was less than the control group and treatment efficiency on the treatment group was higher, the differences were statistically significant （P〈0.05）. The occurrence of two sets of adverse reactions was no significant difference. Conclusion amiodarone metoprolol intravenous injection in the treatment of tachyarrhythmia, the onset time is faster and does not increase the incidence of complications advantages, it is worth in clinical practice.
出处
《当代医学》
2012年第28期141-142,共2页
Contemporary Medicine
